United States Antimony Corp (UAMY) concluded trading on Thursday at a closing price of $2.06, with 3.89 million shares of worth about $8.01 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 450.07% during that period and on February 13, 2025 the price saw a gain of about 7.29%. Currently the company’s common shares owned by public are about 108.44M shares, out of which, 82.73M shares are available for trading.
Stock saw a price change of 10.75% in past 5 days and over the past one month there was a price change of 32.90%. Year-to-date (YTD), UAMY shares are showing a performance of 16.38% which increased to 815.56% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.17 but also hit the highest price of $2.35 during that period. The average intraday trading volume for United States Antimony Corp shares is 4.18 million. The stock is currently trading 13.53% above its 20-day simple moving average (SMA20), while that difference is up 19.39% for SMA50 and it goes to 157.37% higher than SMA200.
United States Antimony Corp (AMEX: UAMY) currently have 108.44M outstanding shares and institutions hold larger chunk of about 18.99% of that.
The stock has a current market capitalization of $223.40M and its 3Y-monthly beta is at 0.62. It has posted earnings per share of -$0.04 in the same period. It has Quick Ratio of 5.84 while making debt-to-equity ratio of 0.05. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for UAMY, volatility over the week remained 9.50% while standing at 8.94% over the month.
Stock’s fiscal year EPS is expected to rise by 66.67% while it is estimated to increase by 375.00% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by H.C. Wainwright on December 10, 2024 offering a Buy rating for the stock and assigned a target price of $2.50 to it.
